nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—NISCH—Vincristine—Vinblastine—kidney cancer	0.0124	0.554	CbGdCrCtD
Phentolamine—NISCH—Vinblastine—Vincristine—kidney cancer	0.00997	0.446	CbGdCrCtD
Phentolamine—Hypertension—Temsirolimus—kidney cancer	0.00389	0.00401	CcSEcCtD
Phentolamine—Chest pain—Temsirolimus—kidney cancer	0.00383	0.00395	CcSEcCtD
Phentolamine—Acute coronary syndrome—Sorafenib—kidney cancer	0.00367	0.00378	CcSEcCtD
Phentolamine—Hypertension—Pazopanib—kidney cancer	0.00366	0.00378	CcSEcCtD
Phentolamine—Myocardial infarction—Sorafenib—kidney cancer	0.00365	0.00376	CcSEcCtD
Phentolamine—Chest pain—Pazopanib—kidney cancer	0.00361	0.00372	CcSEcCtD
Phentolamine—Nervous system disorder—Temsirolimus—kidney cancer	0.0036	0.00372	CcSEcCtD
Phentolamine—Cardiac disorder—Everolimus—kidney cancer	0.00357	0.00368	CcSEcCtD
Phentolamine—Flushing—Everolimus—kidney cancer	0.00357	0.00368	CcSEcCtD
Phentolamine—Acute coronary syndrome—Sunitinib—kidney cancer	0.00353	0.00364	CcSEcCtD
Phentolamine—Blood pressure increased—Capecitabine—kidney cancer	0.00353	0.00364	CcSEcCtD
Phentolamine—Injection site reaction—Capecitabine—kidney cancer	0.00351	0.00362	CcSEcCtD
Phentolamine—Angiopathy—Everolimus—kidney cancer	0.00349	0.0036	CcSEcCtD
Phentolamine—Mediastinal disorder—Everolimus—kidney cancer	0.00347	0.00358	CcSEcCtD
Phentolamine—Nasal congestion—Paclitaxel—kidney cancer	0.00342	0.00353	CcSEcCtD
Phentolamine—Nervous system disorder—Pazopanib—kidney cancer	0.00339	0.0035	CcSEcCtD
Phentolamine—Mediastinal disorder—Erlotinib—kidney cancer	0.00334	0.00345	CcSEcCtD
Phentolamine—Arrhythmia—Erlotinib—kidney cancer	0.00332	0.00342	CcSEcCtD
Phentolamine—Bradycardia—Sunitinib—kidney cancer	0.00327	0.00337	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00317	0.00327	CcSEcCtD
Phentolamine—Pain—Temsirolimus—kidney cancer	0.00314	0.00324	CcSEcCtD
Phentolamine—Paraesthesia—Pazopanib—kidney cancer	0.00311	0.00321	CcSEcCtD
Phentolamine—Flushing—Sorafenib—kidney cancer	0.0031	0.0032	CcSEcCtD
Phentolamine—Cardiac disorder—Sorafenib—kidney cancer	0.0031	0.0032	CcSEcCtD
Phentolamine—Angiopathy—Sorafenib—kidney cancer	0.00303	0.00312	CcSEcCtD
Phentolamine—Mediastinal disorder—Sorafenib—kidney cancer	0.00301	0.0031	CcSEcCtD
Phentolamine—Gastrointestinal pain—Temsirolimus—kidney cancer	0.003	0.0031	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00299	0.00308	CcSEcCtD
Phentolamine—Acute coronary syndrome—Vincristine—kidney cancer	0.00298	0.00308	CcSEcCtD
Phentolamine—Arrhythmia—Sorafenib—kidney cancer	0.00298	0.00308	CcSEcCtD
Phentolamine—Flushing—Sunitinib—kidney cancer	0.00298	0.00308	CcSEcCtD
Phentolamine—Cardiac disorder—Sunitinib—kidney cancer	0.00298	0.00308	CcSEcCtD
Phentolamine—Myocardial infarction—Vincristine—kidney cancer	0.00297	0.00306	CcSEcCtD
Phentolamine—Pain—Pazopanib—kidney cancer	0.00296	0.00305	CcSEcCtD
Phentolamine—Angiopathy—Sunitinib—kidney cancer	0.00291	0.00301	CcSEcCtD
Phentolamine—Abdominal pain—Temsirolimus—kidney cancer	0.0029	0.003	CcSEcCtD
Phentolamine—Hypertension—Vinblastine—kidney cancer	0.0029	0.00299	CcSEcCtD
Phentolamine—Mediastinal disorder—Sunitinib—kidney cancer	0.0029	0.00299	CcSEcCtD
Phentolamine—Hypertension—Everolimus—kidney cancer	0.00289	0.00298	CcSEcCtD
Phentolamine—Arrhythmia—Sunitinib—kidney cancer	0.00287	0.00296	CcSEcCtD
Phentolamine—Chest pain—Everolimus—kidney cancer	0.00285	0.00294	CcSEcCtD
Phentolamine—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00285	0.00294	CcSEcCtD
Phentolamine—Abdominal pain upper—Paclitaxel—kidney cancer	0.00285	0.00294	CcSEcCtD
Phentolamine—Acute coronary syndrome—Gemcitabine—kidney cancer	0.00283	0.00292	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pazopanib—kidney cancer	0.00283	0.00292	CcSEcCtD
Phentolamine—Flushing—Dactinomycin—kidney cancer	0.00282	0.00291	CcSEcCtD
Phentolamine—Myocardial infarction—Gemcitabine—kidney cancer	0.00281	0.0029	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—kidney cancer	0.00278	0.00287	CcSEcCtD
Phentolamine—Chest pain—Erlotinib—kidney cancer	0.00275	0.00284	CcSEcCtD
Phentolamine—Abdominal pain—Pazopanib—kidney cancer	0.00274	0.00282	CcSEcCtD
Phentolamine—Nervous system disorder—Everolimus—kidney cancer	0.00268	0.00276	CcSEcCtD
Phentolamine—Tachycardia—Everolimus—kidney cancer	0.00267	0.00275	CcSEcCtD
Phentolamine—Asthenia—Temsirolimus—kidney cancer	0.00264	0.00272	CcSEcCtD
Phentolamine—Pruritus—Temsirolimus—kidney cancer	0.0026	0.00268	CcSEcCtD
Phentolamine—Nervous system disorder—Erlotinib—kidney cancer	0.00259	0.00267	CcSEcCtD
Phentolamine—Hypotension—Everolimus—kidney cancer	0.00255	0.00263	CcSEcCtD
Phentolamine—Cardiac disorder—Vincristine—kidney cancer	0.00252	0.0026	CcSEcCtD
Phentolamine—Diarrhoea—Temsirolimus—kidney cancer	0.00251	0.00259	CcSEcCtD
Phentolamine—Hypertension—Sorafenib—kidney cancer	0.00251	0.00259	CcSEcCtD
Phentolamine—Asthenia—Pazopanib—kidney cancer	0.00248	0.00256	CcSEcCtD
Phentolamine—Angiopathy—Vincristine—kidney cancer	0.00247	0.00254	CcSEcCtD
Phentolamine—Paraesthesia—Vinblastine—kidney cancer	0.00246	0.00254	CcSEcCtD
Phentolamine—Paraesthesia—Everolimus—kidney cancer	0.00245	0.00253	CcSEcCtD
Phentolamine—Mediastinal disorder—Vincristine—kidney cancer	0.00245	0.00253	CcSEcCtD
Phentolamine—Pruritus—Pazopanib—kidney cancer	0.00245	0.00253	CcSEcCtD
Phentolamine—Dizziness—Temsirolimus—kidney cancer	0.00243	0.00251	CcSEcCtD
Phentolamine—Hypertension—Sunitinib—kidney cancer	0.00241	0.00249	CcSEcCtD
Phentolamine—Cardiac disorder—Gemcitabine—kidney cancer	0.00239	0.00247	CcSEcCtD
Phentolamine—Chest pain—Sunitinib—kidney cancer	0.00238	0.00246	CcSEcCtD
Phentolamine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00237	0.00244	CcSEcCtD
Phentolamine—Diarrhoea—Pazopanib—kidney cancer	0.00237	0.00244	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Everolimus—kidney cancer	0.00236	0.00243	CcSEcCtD
Phentolamine—Myocardial infarction—Paclitaxel—kidney cancer	0.00236	0.00243	CcSEcCtD
Phentolamine—Pain—Vinblastine—kidney cancer	0.00235	0.00242	CcSEcCtD
Phentolamine—Angiopathy—Gemcitabine—kidney cancer	0.00234	0.00241	CcSEcCtD
Phentolamine—Orthostatic hypotension—Capecitabine—kidney cancer	0.00234	0.00241	CcSEcCtD
Phentolamine—Abdominal pain upper—Capecitabine—kidney cancer	0.00234	0.00241	CcSEcCtD
Phentolamine—Pain—Everolimus—kidney cancer	0.00234	0.00241	CcSEcCtD
Phentolamine—Vomiting—Temsirolimus—kidney cancer	0.00234	0.00241	CcSEcCtD
Phentolamine—Nervous system disorder—Sorafenib—kidney cancer	0.00233	0.0024	CcSEcCtD
Phentolamine—Mediastinal disorder—Gemcitabine—kidney cancer	0.00232	0.0024	CcSEcCtD
Phentolamine—Arrhythmia—Gemcitabine—kidney cancer	0.0023	0.00238	CcSEcCtD
Phentolamine—Headache—Temsirolimus—kidney cancer	0.0023	0.00237	CcSEcCtD
Phentolamine—Dizziness—Pazopanib—kidney cancer	0.00229	0.00236	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00228	0.00235	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—kidney cancer	0.00226	0.00233	CcSEcCtD
Phentolamine—Pain—Erlotinib—kidney cancer	0.00225	0.00233	CcSEcCtD
Phentolamine—Gastrointestinal pain—Vinblastine—kidney cancer	0.00224	0.00231	CcSEcCtD
Phentolamine—Nervous system disorder—Sunitinib—kidney cancer	0.00224	0.00231	CcSEcCtD
Phentolamine—Gastrointestinal pain—Everolimus—kidney cancer	0.00223	0.0023	CcSEcCtD
Phentolamine—Vomiting—Pazopanib—kidney cancer	0.0022	0.00227	CcSEcCtD
Phentolamine—Bradycardia—Paclitaxel—kidney cancer	0.0022	0.00227	CcSEcCtD
Phentolamine—Nausea—Temsirolimus—kidney cancer	0.00218	0.00225	CcSEcCtD
Phentolamine—Abdominal pain—Vinblastine—kidney cancer	0.00217	0.00224	CcSEcCtD
Phentolamine—Headache—Pazopanib—kidney cancer	0.00217	0.00224	CcSEcCtD
Phentolamine—Abdominal pain—Everolimus—kidney cancer	0.00216	0.00223	CcSEcCtD
Phentolamine—Gastrointestinal pain—Erlotinib—kidney cancer	0.00216	0.00222	CcSEcCtD
Phentolamine—Angina pectoris—Capecitabine—kidney cancer	0.00216	0.00222	CcSEcCtD
Phentolamine—Abdominal pain—Erlotinib—kidney cancer	0.00208	0.00215	CcSEcCtD
Phentolamine—Nausea—Pazopanib—kidney cancer	0.00206	0.00212	CcSEcCtD
Phentolamine—Paraesthesia—Sunitinib—kidney cancer	0.00205	0.00211	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00205	0.00211	CcSEcCtD
Phentolamine—Hypertension—Vincristine—kidney cancer	0.00204	0.00211	CcSEcCtD
Phentolamine—Pain—Sorafenib—kidney cancer	0.00203	0.00209	CcSEcCtD
Phentolamine—Cardiac disorder—Paclitaxel—kidney cancer	0.002	0.00207	CcSEcCtD
Phentolamine—Flushing—Paclitaxel—kidney cancer	0.002	0.00207	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00197	0.00203	CcSEcCtD
Phentolamine—Asthenia—Vinblastine—kidney cancer	0.00197	0.00203	CcSEcCtD
Phentolamine—Asthenia—Everolimus—kidney cancer	0.00196	0.00202	CcSEcCtD
Phentolamine—Angiopathy—Paclitaxel—kidney cancer	0.00196	0.00202	CcSEcCtD
Phentolamine—Pain—Sunitinib—kidney cancer	0.00195	0.00201	CcSEcCtD
Phentolamine—Mediastinal disorder—Paclitaxel—kidney cancer	0.00195	0.00201	CcSEcCtD
Phentolamine—Acute coronary syndrome—Capecitabine—kidney cancer	0.00194	0.00201	CcSEcCtD
Phentolamine—Gastrointestinal pain—Sorafenib—kidney cancer	0.00194	0.002	CcSEcCtD
Phentolamine—Hypertension—Gemcitabine—kidney cancer	0.00194	0.002	CcSEcCtD
Phentolamine—Myocardial infarction—Capecitabine—kidney cancer	0.00193	0.00199	CcSEcCtD
Phentolamine—Pruritus—Everolimus—kidney cancer	0.00193	0.00199	CcSEcCtD
Phentolamine—Arrhythmia—Paclitaxel—kidney cancer	0.00193	0.00199	CcSEcCtD
Phentolamine—Chest pain—Gemcitabine—kidney cancer	0.00191	0.00197	CcSEcCtD
Phentolamine—Nervous system disorder—Vincristine—kidney cancer	0.00189	0.00195	CcSEcCtD
Phentolamine—Asthenia—Erlotinib—kidney cancer	0.00189	0.00195	CcSEcCtD
Phentolamine—Diarrhoea—Vinblastine—kidney cancer	0.00188	0.00194	CcSEcCtD
Phentolamine—Abdominal pain—Sorafenib—kidney cancer	0.00188	0.00193	CcSEcCtD
Phentolamine—Diarrhoea—Everolimus—kidney cancer	0.00187	0.00193	CcSEcCtD
Phentolamine—Gastrointestinal pain—Sunitinib—kidney cancer	0.00187	0.00193	CcSEcCtD
Phentolamine—Pruritus—Erlotinib—kidney cancer	0.00187	0.00192	CcSEcCtD
Phentolamine—Pain—Dactinomycin—kidney cancer	0.00185	0.00191	CcSEcCtD
Phentolamine—Dizziness—Vinblastine—kidney cancer	0.00181	0.00187	CcSEcCtD
Phentolamine—Dizziness—Everolimus—kidney cancer	0.00181	0.00186	CcSEcCtD
Phentolamine—Abdominal pain—Sunitinib—kidney cancer	0.0018	0.00186	CcSEcCtD
Phentolamine—Diarrhoea—Erlotinib—kidney cancer	0.0018	0.00186	CcSEcCtD
Phentolamine—Hypotension—Vincristine—kidney cancer	0.0018	0.00186	CcSEcCtD
Phentolamine—Bradycardia—Capecitabine—kidney cancer	0.0018	0.00186	CcSEcCtD
Phentolamine—Nervous system disorder—Gemcitabine—kidney cancer	0.0018	0.00185	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00177	0.00182	CcSEcCtD
Phentolamine—Vomiting—Vinblastine—kidney cancer	0.00174	0.0018	CcSEcCtD
Phentolamine—Dizziness—Erlotinib—kidney cancer	0.00174	0.0018	CcSEcCtD
Phentolamine—Vomiting—Everolimus—kidney cancer	0.00174	0.00179	CcSEcCtD
Phentolamine—Paraesthesia—Vincristine—kidney cancer	0.00173	0.00179	CcSEcCtD
Phentolamine—Headache—Vinblastine—kidney cancer	0.00172	0.00177	CcSEcCtD
Phentolamine—Headache—Everolimus—kidney cancer	0.00171	0.00177	CcSEcCtD
Phentolamine—Hypotension—Gemcitabine—kidney cancer	0.00171	0.00177	CcSEcCtD
Phentolamine—Abdominal pain—Dactinomycin—kidney cancer	0.00171	0.00176	CcSEcCtD
Phentolamine—Asthenia—Sorafenib—kidney cancer	0.0017	0.00176	CcSEcCtD
Phentolamine—Pruritus—Sorafenib—kidney cancer	0.00168	0.00173	CcSEcCtD
Phentolamine—Vomiting—Erlotinib—kidney cancer	0.00168	0.00173	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Vincristine—kidney cancer	0.00167	0.00172	CcSEcCtD
Phentolamine—Headache—Erlotinib—kidney cancer	0.00165	0.0017	CcSEcCtD
Phentolamine—Pain—Vincristine—kidney cancer	0.00165	0.0017	CcSEcCtD
Phentolamine—Paraesthesia—Gemcitabine—kidney cancer	0.00164	0.0017	CcSEcCtD
Phentolamine—Flushing—Capecitabine—kidney cancer	0.00164	0.0017	CcSEcCtD
Phentolamine—Cardiac disorder—Capecitabine—kidney cancer	0.00164	0.0017	CcSEcCtD
Phentolamine—Asthenia—Sunitinib—kidney cancer	0.00164	0.00169	CcSEcCtD
Phentolamine—Nausea—Vinblastine—kidney cancer	0.00163	0.00168	CcSEcCtD
Phentolamine—Nausea—Everolimus—kidney cancer	0.00162	0.00167	CcSEcCtD
Phentolamine—Diarrhoea—Sorafenib—kidney cancer	0.00162	0.00167	CcSEcCtD
Phentolamine—Hypertension—Paclitaxel—kidney cancer	0.00162	0.00167	CcSEcCtD
Phentolamine—Pruritus—Sunitinib—kidney cancer	0.00161	0.00167	CcSEcCtD
Phentolamine—Angiopathy—Capecitabine—kidney cancer	0.00161	0.00166	CcSEcCtD
Phentolamine—Chest pain—Paclitaxel—kidney cancer	0.0016	0.00165	CcSEcCtD
Phentolamine—Mediastinal disorder—Capecitabine—kidney cancer	0.0016	0.00165	CcSEcCtD
Phentolamine—Arrhythmia—Capecitabine—kidney cancer	0.00158	0.00163	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00158	0.00163	CcSEcCtD
Phentolamine—Gastrointestinal pain—Vincristine—kidney cancer	0.00158	0.00163	CcSEcCtD
Phentolamine—Dizziness—Sorafenib—kidney cancer	0.00157	0.00162	CcSEcCtD
Phentolamine—Pain—Gemcitabine—kidney cancer	0.00157	0.00162	CcSEcCtD
Phentolamine—Nausea—Erlotinib—kidney cancer	0.00157	0.00162	CcSEcCtD
Phentolamine—Diarrhoea—Sunitinib—kidney cancer	0.00156	0.00161	CcSEcCtD
Phentolamine—Asthenia—Dactinomycin—kidney cancer	0.00155	0.0016	CcSEcCtD
Phentolamine—Abdominal pain—Vincristine—kidney cancer	0.00153	0.00157	CcSEcCtD
Phentolamine—Dizziness—Sunitinib—kidney cancer	0.00151	0.00156	CcSEcCtD
Phentolamine—Vomiting—Sorafenib—kidney cancer	0.00151	0.00156	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—kidney cancer	0.00151	0.00155	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00151	0.00155	CcSEcCtD
Phentolamine—Nervous system disorder—Paclitaxel—kidney cancer	0.0015	0.00155	CcSEcCtD
Phentolamine—Tachycardia—Paclitaxel—kidney cancer	0.0015	0.00154	CcSEcCtD
Phentolamine—Headache—Sorafenib—kidney cancer	0.00149	0.00153	CcSEcCtD
Phentolamine—Diarrhoea—Dactinomycin—kidney cancer	0.00148	0.00152	CcSEcCtD
Phentolamine—Vomiting—Sunitinib—kidney cancer	0.00145	0.0015	CcSEcCtD
Phentolamine—Hypotension—Paclitaxel—kidney cancer	0.00143	0.00148	CcSEcCtD
Phentolamine—Headache—Sunitinib—kidney cancer	0.00143	0.00147	CcSEcCtD
Phentolamine—Nausea—Sorafenib—kidney cancer	0.00141	0.00145	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—kidney cancer	0.00139	0.00143	CcSEcCtD
Phentolamine—Asthenia—Vincristine—kidney cancer	0.00139	0.00143	CcSEcCtD
Phentolamine—Paraesthesia—Paclitaxel—kidney cancer	0.00138	0.00142	CcSEcCtD
Phentolamine—Vomiting—Dactinomycin—kidney cancer	0.00137	0.00142	CcSEcCtD
Phentolamine—Nausea—Sunitinib—kidney cancer	0.00136	0.0014	CcSEcCtD
Phentolamine—Hypertension—Capecitabine—kidney cancer	0.00133	0.00137	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00132	0.00137	CcSEcCtD
Phentolamine—Diarrhoea—Vincristine—kidney cancer	0.00132	0.00136	CcSEcCtD
Phentolamine—Asthenia—Gemcitabine—kidney cancer	0.00131	0.00136	CcSEcCtD
Phentolamine—Chest pain—Capecitabine—kidney cancer	0.00131	0.00135	CcSEcCtD
Phentolamine—Pain—Paclitaxel—kidney cancer	0.00131	0.00135	CcSEcCtD
Phentolamine—Pruritus—Gemcitabine—kidney cancer	0.0013	0.00134	CcSEcCtD
Phentolamine—Nausea—Dactinomycin—kidney cancer	0.00128	0.00132	CcSEcCtD
Phentolamine—Dizziness—Vincristine—kidney cancer	0.00128	0.00132	CcSEcCtD
Phentolamine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00125	0.00129	CcSEcCtD
Phentolamine—Diarrhoea—Gemcitabine—kidney cancer	0.00125	0.00129	CcSEcCtD
Phentolamine—Nervous system disorder—Capecitabine—kidney cancer	0.00123	0.00127	CcSEcCtD
Phentolamine—Tachycardia—Capecitabine—kidney cancer	0.00123	0.00127	CcSEcCtD
Phentolamine—Vomiting—Vincristine—kidney cancer	0.00123	0.00127	CcSEcCtD
Phentolamine—Abdominal pain—Paclitaxel—kidney cancer	0.00121	0.00125	CcSEcCtD
Phentolamine—Headache—Vincristine—kidney cancer	0.00121	0.00125	CcSEcCtD
Phentolamine—Hypotension—Capecitabine—kidney cancer	0.00118	0.00121	CcSEcCtD
Phentolamine—Vomiting—Gemcitabine—kidney cancer	0.00116	0.0012	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—kidney cancer	0.00116	0.0012	CcSEcCtD
Phentolamine—Headache—Gemcitabine—kidney cancer	0.00115	0.00118	CcSEcCtD
Phentolamine—Nausea—Vincristine—kidney cancer	0.00115	0.00118	CcSEcCtD
Phentolamine—Paraesthesia—Capecitabine—kidney cancer	0.00113	0.00117	CcSEcCtD
Phentolamine—Asthenia—Paclitaxel—kidney cancer	0.0011	0.00113	CcSEcCtD
Phentolamine—Nausea—Gemcitabine—kidney cancer	0.00109	0.00112	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00109	0.00112	CcSEcCtD
Phentolamine—Pruritus—Paclitaxel—kidney cancer	0.00108	0.00112	CcSEcCtD
Phentolamine—Pain—Capecitabine—kidney cancer	0.00108	0.00111	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—kidney cancer	0.00106	0.00109	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—kidney cancer	0.00106	0.00109	CcSEcCtD
Phentolamine—Diarrhoea—Paclitaxel—kidney cancer	0.00105	0.00108	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—kidney cancer	0.00104	0.00107	CcSEcCtD
Phentolamine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00103	0.00106	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—kidney cancer	0.00103	0.00106	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—kidney cancer	0.00102	0.00105	CcSEcCtD
Phentolamine—Dizziness—Paclitaxel—kidney cancer	0.00101	0.00105	CcSEcCtD
Phentolamine—Abdominal pain—Capecitabine—kidney cancer	0.000995	0.00103	CcSEcCtD
Phentolamine—Vomiting—Paclitaxel—kidney cancer	0.000975	0.00101	CcSEcCtD
Phentolamine—NISCH—nephron tubule—kidney cancer	0.000972	0.12	CbGeAlD
Phentolamine—Headache—Paclitaxel—kidney cancer	0.000961	0.000991	CcSEcCtD
Phentolamine—Nausea—Paclitaxel—kidney cancer	0.000911	0.000939	CcSEcCtD
Phentolamine—Asthenia—Capecitabine—kidney cancer	0.000903	0.000931	CcSEcCtD
Phentolamine—Pruritus—Capecitabine—kidney cancer	0.00089	0.000918	CcSEcCtD
Phentolamine—Diarrhoea—Capecitabine—kidney cancer	0.000861	0.000888	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—kidney cancer	0.000858	0.000885	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—kidney cancer	0.000846	0.000873	CcSEcCtD
Phentolamine—Dizziness—Capecitabine—kidney cancer	0.000832	0.000858	CcSEcCtD
Phentolamine—NISCH—cortex of kidney—kidney cancer	0.000832	0.103	CbGeAlD
Phentolamine—Vomiting—Capecitabine—kidney cancer	0.0008	0.000825	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—kidney cancer	0.000795	0.00082	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—kidney cancer	0.000792	0.000816	CcSEcCtD
Phentolamine—Headache—Capecitabine—kidney cancer	0.000788	0.000813	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—kidney cancer	0.000758	0.000782	CcSEcCtD
Phentolamine—ADRA1B—renal system—kidney cancer	0.000754	0.0933	CbGeAlD
Phentolamine—Nausea—Capecitabine—kidney cancer	0.000747	0.000771	CcSEcCtD
Phentolamine—ADRA1B—kidney—kidney cancer	0.000729	0.0902	CbGeAlD
Phentolamine—Paraesthesia—Doxorubicin—kidney cancer	0.000728	0.000751	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.0007	0.000722	CcSEcCtD
Phentolamine—Pain—Doxorubicin—kidney cancer	0.000694	0.000715	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000663	0.000684	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—kidney cancer	0.000641	0.000661	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—kidney cancer	0.000582	0.0006	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—kidney cancer	0.000574	0.000592	CcSEcCtD
Phentolamine—SIGMAR1—nephron tubule—kidney cancer	0.000565	0.07	CbGeAlD
Phentolamine—Diarrhoea—Doxorubicin—kidney cancer	0.000555	0.000572	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—kidney cancer	0.000536	0.000553	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—kidney cancer	0.000516	0.000532	CcSEcCtD
Phentolamine—Headache—Doxorubicin—kidney cancer	0.000508	0.000524	CcSEcCtD
Phentolamine—SIGMAR1—cortex of kidney—kidney cancer	0.000484	0.0599	CbGeAlD
Phentolamine—Nausea—Doxorubicin—kidney cancer	0.000482	0.000497	CcSEcCtD
Phentolamine—SIGMAR1—cardiac atrium—kidney cancer	0.00046	0.057	CbGeAlD
Phentolamine—ADRA2C—nephron tubule—kidney cancer	0.000444	0.055	CbGeAlD
Phentolamine—ADRA1A—renal system—kidney cancer	0.000424	0.0524	CbGeAlD
Phentolamine—ADRA2C—renal system—kidney cancer	0.000404	0.05	CbGeAlD
Phentolamine—ADRA2C—kidney—kidney cancer	0.00039	0.0483	CbGeAlD
Phentolamine—ADRA2C—cortex of kidney—kidney cancer	0.00038	0.047	CbGeAlD
Phentolamine—ADRA2C—cardiac atrium—kidney cancer	0.000361	0.0447	CbGeAlD
Phentolamine—ADRA2A—cortex of kidney—kidney cancer	0.000303	0.0375	CbGeAlD
Phentolamine—ADRA2A—gonad—kidney cancer	0.000289	0.0357	CbGeAlD
Phentolamine—ADRA2A—cardiac atrium—kidney cancer	0.000288	0.0357	CbGeAlD
